“…Due to their ability to be easily manipulated by magnetic field gradients and the negligible magnetic background of biological objects, superparamagnetic particles have been increasingly used as labels in volumetric assays (Borlido et al, 2013;Issadore et al, 2014). In biosensing platforms based on the detection of the presence or absence of magnetic particle labeled targets, the read-out is performed in various magnetic stray field detection devices, measuring changes in either static or dynamic properties of the magnetic particles upon interaction with the target, such as magnetoresistance sensors (Baselt et al, 1998;Graham et al, 2003;Dalslet et al, 2011), Hall effect devices (Mihajlovic et al, 2005;Sandhu et al, 2007;Østerberg et al, 2014), magnetic tunnel junctions (Grancharov et al, 2005), superconducting quantum interference devices (Chemla et al, 2000;Grossman et al, 2004;Strömberg et al, 2008), or AC susceptometers (Astalan et al, 2004;Park et al, 2011;Zardán Gómez de la Torre et al, 2011). On the one hand, by employing enzymatic amplification strategies for improving the sensitivity, those magnetic biosensors are capable of detecting nucleic acid targets with a limit of detection (LOD) in the low pM range (Dalslet et al, 2011;Østerberg et al, 2014;Strömberg et al, 2008; Torre et al, 2011).…”